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Dear Editor-in-Chief 
 
Herbal medicines have been traditionally used for 
the treatment of diabetes mellitus (1). Some me-
dicinal plants contain compounds that can be 
effective in impaired glucose tolerance. Recent 
pre-clinical and clinical trials have also demon-
strated their beneficial effects on diabetes associ-
ated complications, especially on diabetic 
nephropathy (2-7). Although some plants have 
been shown to have toxic effects (8), hut several 
species with beneficial effects on diabetes mellitus 
and in the prevention of kidney complications in 
diabetic patients have been identified. These ef-
fects have been observed with both bioactive com-
pounds and crude extracts isolated from anti-dia-
betic plants. In particular, plants such as Sclerocarya 
birrea, Persea americana, Ficus thonningii and Helichry-
sium ceres have been shown to have renoprotective 
effects (9-12). Isolated compounds such as 
oleanolic acid have also been shown to possess 
renoprotective effects in experimental diabetes in 
animals. Hence oleanolic  acid  caused  an increase 
in  renal  Na+ excretion in streptozotocin-induced 
diabetic rats, which was mediated by an improve-
ment  in  glomerular  filtration  rate (13).  
Initial studies have shown that these plants amelio-
rated kidney dysfunction in experimentally in-
duced diabetes in rodents. However, the exact ef-
fects on human are not clear and should be estab-
lished. There are various mechanisms by which 
renoprotection may be achieved, including in-
crease in formation of advanced glycation end-
products (AGEs), oxidative stress, and activation 
of hexosamine flux, causing inflammation and 
kidney injury. Advanced glycation end-products 
reduce matrix protein flexibility through cross-link 
formation of the extracellular matrix proteins. This 
can cause abnormal interaction with other matrix 
components. Increase in production of advanced 
glycation end-products may result in an increase in 
production of proteins of  mesangial cells and 
macrophages extracellular matrix as well as in en-
dothelial cells. 
Alteration in the mesangial cell function is the main 
cause of decreased renal function in diabetic pa-
tients (14). Indeed, when nephropathy progresses,  
t he  decline in glomerular filtration rate may be 
due to expansion of the mesangial matrix. This 
phenomenon compresses the glomerular capillar-
ies, resulting in reduction in the filtration surface 
area and impairment in maintaining the normal 
glomerular capillary hydrostatic pressure (13,14). 
Sustained hyperglycemia is the main cause of 
change in kidney function in diabetic patients.  
Various renoprotective agents have shown to act 
through antioxidant activity and/or reduction in 
AGEs production.  Additionally, some plants 
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have shown to cause an improvement in kidney 
function in experimental diabetes mellitus through 
inhibition of ET-1 and TGF-β1 and the endo-
thelin-1 receptor A (ETRA) (15). Some medicinal 
plants interfere with the diluting and concentrating 
mechanisms of tubular transport processes in the 
proximal and distal tubules or other components 
of tubular cell membranes (16,17). Therefore, we 
may speculate that the compound such as oleanol-
ic acid influence renal fluid and electrolyte han-
dling by alteration of the structural integrity and 
function of tubular epithelial cells to affect reab-
sorption and secretion. As it was mentioned, oxi-
dative stress is one of the main causes of kidney 
dysfunction in diabetic patients as well as reno-
toxic agents such as gentamicin (18,19). Most of 
medicinal plants have been shown to act by reduc-
tion of oxidative stress (16,17). Oxidative stress is 
usually induced by increase in reactive oxygen spe-
cies (ROS) and/or reactive nitrogen species (RNS) 
and/or decrease in body antioxidants. This imbal-
ance between the level of production and/or re-
moval of cell oxidants causes a decline in the abil-
ity of biological systems to detoxify the reactive 
components or repair of the resulting damages 
(14-17).  
Although renal toxicity other than diabetes may 
also be induced by other complications such as 
chronic kidney disease or vascular complications, 
however, all induced oxidative stress, will put the 
patients at higher risk of acute renal failure due to 
ischemic and nephrotoxic insults too (16,17). Me-
dicinal plants which mostly possess antioxidant 
properties have shown to be effective in the pre-
vention and treatment of oxidative stress-related 
renal injury. The antioxidant activities of plants 
have been related to various phytochemicals, 
however phenolic compounds, especially phenolic 
acids, flavonoids, anthocyanins and tannins are 
mostly involved (15-17). These antioxidants elabo-
rate endogenous antioxidants capacity to protect 
renal damage by reduction of lipid peroxidation. 
In this regard, the beneficial effect of single or 
combination of antioxidants is more in human is 
not clear and need to be established.  
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